Hendricks, 2022 - Google Patents
Dynamics of HIV Reservoirs During Sequential ATIHendricks, 2022
View PDF- Document ID
- 8647794679535336508
- Author
- Hendricks C
- Publication year
External Links
Snippet
HIV-1 infected individuals undergo viral rebound upon interrupting antiretroviral therapy (ART). Cellular reservoirs are responsible for reigniting plasma viremia and are comprised of CD4+ T cells, myeloid cells, and other potentially uncharacterized cellular or anatomical …
- 210000002383 AT1 0 title abstract description 5
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| German Advisory Committee Blood (Arbeitskreis Blut), Subgroup ‘Assessment of Pathogens Transmissible by Blood' | Human immunodeficiency virus (HIV) | |
| Andrade et al. | A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption | |
| Sanchez et al. | Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals | |
| Dickover et al. | Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants | |
| Zerhouni et al. | Isolation of CD4-independent primary human immunodeficiency virus type 1 isolates that are syncytium inducing and acutely cytopathic for CD8+ lymphocytes | |
| Zhang et al. | Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease | |
| Fujita et al. | Generation of a replication-competent chimeric simian-human immunodeficiency virus carrying env from subtype C clinical isolate through intracellular homologous recombination | |
| Müller-Trutwin et al. | Increase of HIV-1 subtype A in Central African Republic | |
| Ziani et al. | Immune responses and viral persistence in simian/human immunodeficiency virus SHIV. C. CH848-infected rhesus macaques | |
| Curran et al. | Concordance between semen‐derived HIV‐1 proviral DNA and viral RNA hypervariable region 3 (V3) envelope sequences in cases where semen populations are distinct from those present in blood | |
| Hendricks | Dynamics of HIV Reservoirs During Sequential ATI | |
| English et al. | Phylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants | |
| Liang et al. | Morphine increases lamivudine-and nevirapine-induced human immunodeficiency virus-1 drug-resistant mutations in vitro | |
| Bagaya et al. | Functional bottlenecks for generation of HIV-1 intersubtype Env recombinants | |
| Arroyo et al. | Virologic risk factors for vertical transmission of HIV type 1 in Puerto Rico | |
| Tyers et al. | HIV-1 Rebound Virus Consists of a Small Number of Lineages That Entered the Reservoir Close to ART Initiation | |
| Spielvogel | HIV-2 Envelope Entry Dynamics into Host Cell Types | |
| Xiao | Generation of macrophage models to investigate the effect of host factors restricting HIV and HSV infection | |
| Wang et al. | Residual proviral reservoirs: a high risk for HIV persistence and driving forces for viral rebound after analytical treatment interruption. Viruses 2021; 13 (2): 335 | |
| Ode et al. | Development of a novel Macaque-Tropic HIV-1 adapted to cynomolgus macaques | |
| White | ACCURATE CHARACTERIZATION AND MEASUREMENT OF HIV-1 DECAY AND THE STABLE LATENT RESERVOIR | |
| Huang | Integration Sites in the Persistence of Latent HIV-1 | |
| Liu et al. | JVI Accepted Manuscript Posted Online 10 February 2021 J Virol doi: 10.1128/JVI. 02198-20 Copyright© 2021 Ziani et al. | |
| BUCKLEY | Characterisation of the HIV reservoir in individuals living in South East Asia on ART | |
| Varriale | CHARACTERIZATION OF AUTOLOGOUS ANTIBODY NEUTRALIZATION IN THE HIV-1 LATENT RESERVOIR |